Send to

Choose Destination
Am J Obstet Gynecol. 2017 Jun;216(6):576.e1-576.e5. doi: 10.1016/j.ajog.2017.02.026. Epub 2017 Feb 21.

Preventing human papillomavirus-related cancers: we are all in this together.

Author information

Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL.
Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL.


Human papillomavirus-related cancers, which include cervical, vulvovaginal, anal, and oropharyngeal cancers, are on the rise in the United States. Although the human papillomavirus vaccine has been on the market for 10 years, human papillomavirus vaccination rates are well below national goals. Research identified many barriers and facilitators to human papillomavirus vaccination, and provider recommendation remains the most important factor in parental and patient decisions to vaccinate. While much of the burden of human papillomavirus vaccine provision falls on pediatricians and primary care providers, they cannot do it alone. As clinicians who care for a large proportion of human papillomavirus-related conditions, obstetrician-gynecologists and other women's health care providers must share the responsibility for vaccination of eligible patients. Obstetrician-gynecologists can support the efforts to eradicate human papillomavirus-related disease in their patients and their families via multiple avenues, including providing the human papillomavirus vaccine and being community leaders in support of vaccination.


cancer prevention; cervical cancer; cervical dysplasia; human papillomavirus; human papillomavirus vaccination

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center